Evidence map›Paper›PMID 27848966›Full record

ArticleNature communications2016

17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells.

Benjamin Joachim Schmiedel, Grégory Seumois, Daniela Samaniego-Castruita, Justin Cayford, Veronique Schulten, Lukas Chavez, Ferhat Ay, Alessandro Sette, Bjoern Peters, Pandurangan Vijayanand

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Asthma endotypes and theratypes.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Expression of GATA1 in bronchial asthma and its effect on the transcription regulation of theZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  17. Article
  18. Article
  19. SilencingEnvironmental epigenetics · 2025
    Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Benjamin Joachim SchmiedelLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Grégory SeumoisLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Daniela Samaniego-CastruitaLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Justin CayfordLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Veronique SchultenLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Lukas ChavezGerman Cancer Research Center (DKFZ), Division of Pediatric Neurooncology, 69120 Heidelberg, Germany.
Ferhat AyLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Alessandro SetteLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Bjoern PetersLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
Pandurangan VijayanandLa Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.
La Jolla Institute for Immunology · USHeidelberg University · DENational Institute for Health Research · GB

Funding

Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune CellsR24AI108564 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MITCHELL KRONENBERG, Bjoern Peters · 2014 to 2026
$12.1M
Epigenomics of T cells and innate immune cells in human asthmaR01HL114093 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ARSHAD, SYED HASAN, PETERS, BJOERN · 2011 to 2020
$8.5M
Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NHLBI NIH HHS R01 HL114093NIAID NIH HHS R24 AI108564NIAID NIH HHS U19 AI100275NIH HHS S10 OD016262
6 · The paper itself

Abstract

Asthma and autoimmune disease susceptibility has been strongly linked to genetic variants in the 17q21 haploblock that alter the expression of ORMDL3; however, the molecular mechanisms by which these variants perturb gene expression and the cell types in which this effect is most prominent are unclear. We found several 17q21 variants overlapped enhancers present mainly in primary immune cell types. CD4

Indexed as

Genetic Predisposition to DiseaseAsthmaBase SequenceBinding SitesB-LymphocytesCCCTC-Binding FactorCells, CulturedChromosomes, Human, Pair 17Enhancer Elements, GeneticHumansInterleukin-2IntronsPolymorphism, Single NucleotidePromoter Regions, GeneticProtein BindingRisk FactorsCCCTC-Binding FactorCTCF protein, humanInterleukin-2

Identifiers

PMID27848966
PMCPMC5116091
OpenAlexW2553052372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.